Navigation Links
Korea Institute of Toxicology Implementing Xybion's Pristima™
Date:8/13/2009

Enterprise system will facilitate most complex toxicology study designs in South Korea

Cedar Knolls, NJ and Daejeon, South Korea (PRWEB) August 13, 2009 -- Xybion Medical Systems, a world leader in preclinical data management solutions and the developer of Pristima™ the premier preclinical solution on the market, is pleased to announce that Korea Institute of Toxicology (KIT) is upgrading to Pristima at its facilities in Daejeon and Jeongeup, South Korea.    

Since 2002, KIT has been a Xybion client and has used Xybion's previous PATH/TOX SYSTEM suite as an integral business driver; using the system to plan, collect, manage and report all of its General Toxicology data. With this upgrade, KIT has expanded its software licenses to include the Pharmacy and Reproductive Toxicology modules so as to implement the full Pristima suite to cover all of its toxicology studies. With this system upgrade and expansion, KIT also chose to license Xybion's standard validation package to expedite the project and provide for a solid validation project.

Dr. Pradip Banerjee, Xybion's CEO, stated that "this upgrade and expansion of deployed modules at KIT further exemplifies the advantages of a completely integrated system that has more built-in functionality and business intelligence than any other product on the market."

The Daejeon and Jeongeup sites together comprise of over 500,000 square feet of facility space so KIT is the largest, most well-known GLP facility in South Korea and serves markets all over the world. With a vast experience in all study types, combined with highly automated procedures and reporting capabilities, KIT can define, perform and report client studies in record time and with the highest of quality. PATH/TOX SYSTEM and now Pristima, serve to capture and integrate all of the preclinical data at KIT while serving to enforce SOP's, prevent errors and summarize the results.

Myung-Sang Kwon (President) of Korea Toxicology Institute stated "we are very anxious to start using the Pristima system since our evaluation process revealed that it will facilitate our most complex study designs. It seems that Pristima is designed specifically to take into consideration the most modern concepts in toxicology study design and KIT has always been at the forefront of the best scientific approaches."

About Korea Institute of Toxicology
Korea Institute of Toxicology (KIT) is a world-class prestigious non-clinical contract research organization located in South Korea. KIT's GLP system has been certified by Korean and international regulatory authorities based on OECD and US FDA GLP criteria. Also, KIT is the first organization in Asia accredited by AAALAC International. KIT offers a full range of non-clinical research with high scientific standard and competitive pricing. (www.kitox.re.kr/eng/)

About Xybion Medical Systems - Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide. In addition to Pristima, Xybion provides professional services, consulting, training and validation activities to clients throughout the world. (www.xybion.com)

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2739024.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Korean Food and Drug Administration Approval for ActiPatch Achieved
2. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
3. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
4. Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea
5. GeoPharma Adds India, Nepal, Bangladesh, Sri Lanka and South Korea as New Distribution Channels for Mucotrol(TM)
6. BSP Signs Agreement With CMP Trading for Distribution of HyperQ(TM) Stress System, for Early Detection of Ischemic Heart Disease, in South Korea
7. Seventh CyberKnife System in South Korea Purchased
8. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
9. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
10. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):